Skip to content
  • About us
    • About us
    • Executive commitee
    • Board of Directors
    • Scientific advisors
    • Corporate governance
    • ESG
  • myvac
    • myvac – individualized therapeutic vaccines
  • Pipeline
    • Pipeline
    • TG4050
    • TG4070
    • BT-001
    • TG6050
    • Publications and Presentations
    • Clinical trials FAQ
  • Investors
    • Investor Presentation & Contacts
    • Press releases & events
    • Financial Information
    • Stock Information
    • Annual General Meeting
  • Career
  • English
  • French
PHP Toggle Menu

Category: TG6002

Transgene Announces the Success of Its Capital Increase

Results 2025

Published 26 November 2025
Categorized as 2025, dates, dates, Press release, TG6002

Colorectal Cancer Hepatic Metastasis Modeling by Advanced 3D Bioprinting Allows Demonstration of Oncolytic Viral Chemotherapeutic Delivery

P. Erbs, et al. Cancers 2025 Abstract available on the MDPI website – Download the article

Published 19 November 2025
Categorized as -others, 2025, Invir.IO, Publication, TG6002

Contribution of yeast to synthetic virology

C. Rey, et al. Virologie 2025 Read the article on the JLE website – Download the article

Published 25 October 2025
Categorized as -others, 2025, 2025, Myvac, Publication, Publication, publication key en, TG4050, TG6002

TG6002 oncolytic vaccinia virusand chemotherapy synergy: apromising strategy for pancreaticductal adenocarcinoma

J. Foloppe, et al. Frontiers in Microbiology Septembre 2025 – Download the Article

Published 24 September 2025
Categorized as -others, 2025, Publication, TG6002

A Phase I Clinical Trial of Intrahepatic Artery Delivery of TG6002 in Combination with Oral 5-Fluorocytosine in Patients with Liver-Dominant Metastatic Colorectal Cancer

E. J. West et al.Clinical Cancer Research April 2025Download the publication herePublication

Published 15 April 2025
Categorized as -others, 2025, Publication, TG6002

Transgene to Present Multiple Posters Highlighting the Potential of its Exciting Immunotherapy Pipeline at AACR 2023

Transgene to present multiple posters highlighting the potential of its exciting immunotherapy pipeline at AACR2023 15

Published 15 March 2023
Categorized as 2023, dates, Press release, TG4001, TG4050, TG6002, TG6050-en

Transgene announces Financial Calendar for 2023

Transgene announces Financial Calendar for 2023 15

Published 4 January 2023
Categorized as 2023, dates, Invir.IO, Press release, TG6002

R&D Day: Presentations to Highlight Transgene’s Competitive Positioning, Capabilities to Engineer Novel Immunotherapies for Patients with Cancer, and Update on Initial Clinical Data

TRANSGENE R&D DAY

Published 27 September 2022
Categorized as 2022, Invir.IO, Press release, TG4001, TG4001, TG4050, TG6002

Transgene Confirms the Potential of the Intravenous Route of its Invir.IO™ Oncolytic Viruses against Solid Tumors with TG6002 Phase I Data Presented at ESMO Congress 2022

2Transgene Confirms the Potential of the Intravenous Route of its Invir.IO™ Oncolytic Viruses against Solid Tumors with TG6002 Phase I Data Presented at ESMO Congress 2022

Published 12 September 2022
Categorized as 2022, Invir.IO, Press release, TG6002

Updated data of biodistribution and activity of oncolytic virus TG6002 after intravenous administrationin patients with advanced gastrointestinal carcinomas

V. Moreno, et al. ESMO 2022 – Download the Poster

Published 17 April 2022
Categorized as 2022, Publication, TG6002

Posts pagination

Page 1 … Page 4 Older posts
Get to know us

About us

myvac

Pipeline

Investors

Partnering

Company

Career

ESG

Suppliers

Contacts

Legal documents

Legal notices

Privacy Policy

Ethics and compliance

Cookie policy

  • About us
    • About us
    • Executive commitee
    • Board of Directors
    • Scientific advisors
    • Corporate governance
    • ESG
  • myvac
    • myvac – individualized therapeutic vaccines
  • Pipeline
    • Pipeline
    • TG4050
    • TG4070
    • BT-001
    • TG6050
    • Publications and Presentations
    • Clinical trials FAQ
  • Investors
    • Investor Presentation & Contacts
    • Press releases & events
    • Financial Information
    • Stock Information
    • Annual General Meeting
  • Career
  • English
  • French
Menu